|Name of Journal||Artificial Intelligence in Medical Imaging|
|Title Abbreviation||Artif Intell Med Imaging|
|Background||Artificial Intelligence in Medical Imaging (AIMI, Artif Intell Med Imaging) is a high-quality, online, open-access, single-blind peer-reviewed journal that is published by the Baishideng Publishing Group. Accepting both solicited and unsolicited manuscripts, the AIMI mainly publishes high quality clinical research articles to promote the application of artificial intelligence in radiology, pathology image analysis, endoscopy, molecular imaging, and ultrasonography research with the ultimate objective of improving early screening, diagnosis, and treatment of diseases. The types of articles published in the AIMI include Editorial, Opinion Review, Frontier, Review, Minireview, Topic Highlight, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Advances in Diagnosis, Advances in Treatment, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report.|
The primary aim of the AIMI is to provide scholars and readers from various fields of medical imaging research with a platform to publish high quality clinical research articles and communicate their research findings online. In order to ensure the quality, timeliness, fairness, and transparency of manuscript publication, the AIMI has implemented a variety of measures.
First, authors must prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report.
Second, articles published in the AIMI must undergo rigorous cross-international peer review, where peer reviewers and authors come from different countries and independent peer reviewers are chosen by the editorial office, not by authors, to ensure the fairness of peer review.
Third, designation of co-first authors or co-corresponding authors is not permitted.
Fourth, the AIMI accepts a manuscript based mainly on its novelty, innovativeness, data accuracy, picture reliability, clear language expression, and ethical requirements. Of note, peer reviewers will complete the peer review within 7 days, providing a comprehensive evaluation of the scientific and linguistic quality of the manuscript.
Fifth, BPG adopts a 7-day publishing management policy. This means that each step of the publishing process, including manuscript preview, peer review, manuscript revision by authors, final acceptance, language editing, and production and release, must be completed within 7 days.
Finally, the peer review report, author’s response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent, conflict-of-interest statement, CrossCheck detection report, authors’ personal ORCID numbers, funding information, language editing certificate, and other relevant documents will be published online along with the article to ensure that the publishing process is open and transparent.
The AIMI mainly publishes clinical
medical imaging research results
obtained using artificial intelligence technology, including those from the
clinical research of medical imaging as well as its applications in genetic testing,
histopathological diagnosis, cytological diagnosis, imaging diagnosis,
ultrasonic diagnosis, epidemiology, clinical diagnosis, individualized
treatment, radiotherapy, chemotherapy, and biological treatment.
|Open Access||Open access|
is currently no indexing.
is currently no impact factor.
|Article Processing Charge||Article processing charge|
|Article Reprints||Article reprints|
|Help Desk||Help desk|
|Special Statement||Special statement|
|Copyright ©||© 2004-2019 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA|
|Contact Us||Contact us|